Literature DB >> 22047933

Uncertain added value of Global Trigger Tool for monitoring of patient safety in cancer care.

Henriette Lipczak1, Kirsten Neckelmann, Marianne Steding-Jessen, Erik Jakobsen, Janne Lehmann Knudsen.   

Abstract

INTRODUCTION: Monitoring patient safety is a challenging task. The lack of a golden standard has contributed to the recommendation and introduction of several methods. In 2000 the Danish Lung Cancer Registry (DLCR) was established to monitor the clinical management of lung cancer. In 2008 the Global Trigger Tool (GTT) was recommended in Denmark as a tool for the monitoring of patient safety. Ideally, the recommendation of a new tool should be preceded by a critical assessment of its added value.
MATERIAL AND METHODS: Data on complications related to lung cancer surgery from the Department of Cardiothoragic Surgery at Odense University Hospital were collected using the DLCR and the GTT in 2008. The capacity of these two methods to identify complications is compared and discussed.
RESULTS: A total of 59 complications were registered in the DLCR, while 58 complications were registered using the GTT. The two methods were equally good at identifying complications, but the DLCR seemed to be borderline significantly better at detecting arrhythmia, while the GTT was significantly better at detecting "other events".
CONCLUSION: Nearly half of the adverse events identified with the GTT were complications which were also registered by type in the DLCR. The two methods were almost equally good at identifying specific types of complications, but the GTT identified more "other events". The majority of these events were well-known to clinicians. The comparison illustrates why the implementation of new methods should be preceded by critical assessment. In this case, it is crucial to assess whether the current method should be modified by the addition of more patient safety indicators rather than by introducing a new method that partly duplicates existing data.

Entities:  

Mesh:

Year:  2011        PMID: 22047933

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  5 in total

1.  Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.

Authors:  Guillaume Hébert; Florence Netzer; Sylvain Landry Kouakou; François Lemare; Etienne Minvielle
Journal:  Int J Clin Pharm       Date:  2018-02-14

2.  Identifying Previously Undetected Harm: Piloting the Institute for Healthcare Improvement's Global Trigger Tool in the Veterans Health Administration.

Authors:  Hillary J Mull; Caitlin W Brennan; Tiffany Folkes; John Hermos; Jeffrey Chan; Amy K Rosen; Steven R Simon
Journal:  Qual Manag Health Care       Date:  2015 Jul-Sep       Impact factor: 0.926

3.  Variation in detected adverse events using trigger tools: A systematic review and meta-analysis.

Authors:  Luisa C Eggenschwiler; Anne W S Rutjes; Sarah N Musy; Dietmar Ausserhofer; Natascha M Nielen; René Schwendimann; Maria Unbeck; Michael Simon
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

4.  Association between cancer-specific adverse event triggers and mortality: A validation study.

Authors:  Saul N Weingart; Jason Nelson; Benjamin Koethe; Omar Yaghi; Stephan Dunning; Albert Feldman; David Kent; Allison Lipitz-Snyderman
Journal:  Cancer Med       Date:  2020-04-13       Impact factor: 4.452

5.  Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data.

Authors:  Saul N Weingart; Jason Nelson; Benjamin Koethe; Omar Yaghi; Stephan Dunning; Albert Feldman; David M Kent; Allison Lipitz-Snyderman
Journal:  Cancer Med       Date:  2020-01-03       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.